Lyme ImmunoBlot Panel 1 (IB1)

This test detects antibodies to the bacterium Borrelia burgdorferi. Lyme disease is caused by Borrelia burgdorferi and is transmitted to humans through the bite of infected black-legged ticks. Immunoblot testing will confirm a detected screening result.

This panel uses Immunosciences Lab's patented ELISA methodology, as well as the Western Blot technique, to measure 26 different antibodies against Lyme-specific antigens, Borrelia subspecies, and co-infections. It can detect active and chronic Lyme disease, including Lyme arthritis and neuroborreliosis that may be confused with multiple sclerosis.

EBV contributes to more than 30 autoimmune disorders. Detection of IgG or IgM antibodies to various EBV antigens indicates either past infection, primary reactivation, or re-infection with Epstein-Barr Virus or Herpes Type 4.

This test confirms the presence of ongoing Lyme disease based on CDC criteria.

This test is used to detect antibodies specific for B. burgdorferi. This test is intended as the second step in testing serum samples found to have been equivocal or positive using an ELISA or IFA test.